BiotechTube
Home/Scilex Holding/Henry Ji, Ph.D.
HJ

Henry Ji, Ph.D.

Chairman of the Board of Directors

Scilex Holding

Therapeutic Areas

Pain ManagementNeurologyRheumatology

Scilex Holding Pipeline

DrugIndicationPhase
ZTlido® (lidocaine topical system) 1.8%Post-herpetic neuralgia (PHN)Approved
SP-102 (SEMDEXA™)Lumbar radicular pain (sciatica)Phase 3
SP-103 (STRACUVA™)Acute low back painPhase 2
SP-104 (low-dose naltrexone)FibromyalgiaPhase 2
GLOPERBA® (colchicine USP)Gout flare prophylaxisApproved

Leadership Team at Scilex Holding

JS
Jaisim Shah
Chief Executive Officer and President
EC
Elizabeth Czerepak
Chief Financial Officer
JG
Jeffrey Gudin, M.D.
Chief Medical Officer
DL
David Lemus
Chief Commercial Officer
SM
Stephen Ma
Chief Operating Officer and General Counsel
View full Scilex Holding profile